Peer-influenced content. Sources you trust. No registration required. This is HCN.
Dermatology Advisor
A retrospective analysis of FDA postmarketing reports identified textural changes, pigmentary alteration, and subcutaneous fat loss as the most frequently reported adverse events following radiofrequency microneedling, with most cases occurring on the face and submental area.
Dermatology June 4th 2026
Practical Dermatology
The FDA has approved an OTC switch for adapalene/benzoyl peroxide gel (Differin Epiduo) for patients 12 and older, expanding adolescent access to a fixed-dose retinoid combination without a prescription or clinical visit.
Dermatology June 3rd 2026
A 13-year-old boy presents with recurrent erythematous, tender papules on the lateral and dorsal aspects of the distal fingers, first appearing in early December and recurring after a recent skiing trip.
Dermatology May 20th 2026
Medical Professionals Reference (MPR)
A novel oral extended-release minoxidil formulation produced significantly greater non-vellus hair counts and patient-reported coverage improvement than placebo in men with androgenetic alopecia at six months.
Dermatology May 8th 2026
Conexiant
Smartwatch-derived nighttime scratching metrics correlated moderately with disease severity and short-term treatment response in a small pediatric atopic dermatitis cohort.
Dermatology May 7th 2026
TNF-alpha inhibitor exposure was associated with adjusted hazard ratios of 1.99 for basal cell carcinoma, 1.69 for squamous cell carcinoma, and 1.54 for melanoma in a 56,209-patient retrospective cohort.
Dermatology April 28th 2026